FINANCIAL STATEMENT ANALYSIS

USED BY US DEPARTMEN OF EDUCATION, UNIVERSITIES, STUDENTS & ACCOUNTING PRO'S

VentureLine tracks and provides 5-year financial statement analysis on approximately 7,000+ publicly traded companies; the SEC-traceable data is updated weekly. For your convenience you can access that current company financial statement analysis information by clicking directly on the Company Name, visit their Website or enter the Company name or Ticker symbol, e.g. enter 'Microsoft' or 'MSFT' for Microsoft, in the Company Search window below.

FINANCIAL STATEMENT ANALYSIS UPDATED: JULY 24, 2022

Results 51 through 100 of 294

- SIC # 2830

Ticker Exchange Company Financial Reports SIC #
CAI Nasdaq Caris Life Sciences, Inc. 2830
CALC Nasdaq CalciMedica, Inc. 2830
CANF NYSE American Can-Fite BioPharma Ltd. 2830
CAPR Nasdaq Capricor Therapeutics, Inc. 2830
CATX NYSE American Perspective Therapeutics, Inc. 2830
CBIO Nasdaq Crescent Biopharma, Inc. 2830
CCCC Nasdaq C4 Therapeutics, Inc. 2830
CDT Nasdaq CDT Equity Inc. 2830
CHGCY Over the counter Chugai Pharmaceutical Co., Ltd. 2830
CHRS Nasdaq Coherus Oncology, Inc. 2830
CING Nasdaq Cingulate Inc. 2830
CLDI NYSE American Calidi Biotherapeutics, Inc. 2830
CLLS Nasdaq Cellectis S.A. 2830
CLRB Nasdaq Cellectar Biosciences, Inc. 2830
CLYM Nasdaq Climb Bio, Inc. 2830
CMND Nasdaq Clearmind Medicine Inc. 2830
CMPX Nasdaq Compass Therapeutics, Inc. 2830
CNTN Nasdaq Canton Strategic Holdings, Inc. 2830
CNTX Nasdaq Context Therapeutics Inc. 2830
COCP Nasdaq Cocrystal Pharma, Inc. 2830
COLL Nasdaq Collegium Pharmaceutical, Inc. 2830
CORT Nasdaq Corcept Therapeutics Incorporated 2830
CPHI NYSE American China Pharma Holdings, Inc. 2830
CRL New York Charles River Laboratories International 2830
CRMD Nasdaq CorMedix Inc. 2830
CRON Nasdaq Cronos Group Inc. 2830
CRSP Nasdaq CRISPR Therapeutics AG 2830
CRVS Nasdaq Corvus Pharmaceuticals, Inc. 2830
CSPCY Over the counter CSPC Pharmaceutical Group Limited 2830
CTNM Nasdaq Contineum Therapeutics, Inc. 2830
CTOR Nasdaq Citius Oncology, Inc. 2830
CTXR Nasdaq Citius Pharmaceuticals, Inc. 2830
CURX Nasdaq Curanex Pharmaceuticals Inc 2830
CUVL Nasdaq Clinuvel Pharmaceuticals Limited 2830
DFTX Nasdaq Definium Therapeutics, Inc. 2830
DNLI Nasdaq Denali Therapeutics Inc. 2830
DRMA Nasdaq Dermata Therapeutics, Inc. 2830
DRTS Nasdaq Alpha Tau Medical Ltd. 2830
DSNKY Over the counter Daiichi Sankyo Company, Limited 2830
DTIL Nasdaq Precision BioSciences, Inc. 2830
EDSA Nasdaq Edesa Biotech, Inc. 2830
EIKN Nasdaq Eikon Therapeutics, Inc. 2830
ELAN New York Elanco Animal Health Incorporated 2830
ELDN Nasdaq Eledon Pharmaceuticals, Inc. 2830
ELVN Nasdaq Enliven Therapeutics, Inc. 2830
ENLV Nasdaq Enlivex Ltd. 2830
ENSC Nasdaq Ensysce Biosciences, Inc. 2830
EOLS Nasdaq Evolus, Inc. 2830
EQ Nasdaq Equillium, Inc. 2830
ESAIY Over the counter Eisai Co., Ltd. 2830
Results 50 through 100 of 294